Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 854.05
-1.50 (-0.18%)
Apr 29, 2026, 2:05 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 18.03 billion as of April 28, 2026. Its market cap has decreased by -12.26% in one year.
Market Cap
18.03B
Enterprise Value
15.74B
Revenue
8.68B
Ranking
n/a
PE Ratio
27.21
Stock Price
854.05
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 18.03B, an increase of 103.22%. That is a compound annual growth rate of 16.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 18.03B | 8.22% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indoco Remedies | 19.29B |
| Solara Active Pharma Sciences | 23.28B |
| Sakar Healthcare | 13.93B |
| Jagsonpal Pharmaceuticals | 13.67B |
| Beta Drugs | 13.25B |
| Ind-Swift Laboratories | 11.65B |
| Orchid Pharma | 29.68B |
| RPG Life Sciences | 33.27B |